SEASONAL AFFECTIVE DISORDER & LIGHT MEDICINE

Depression That Arrives With the Darkness Is a Biological Signal, Not a Psychiatric One.

Seasonal Affective Disorder (SAD) — the cyclical mood disorder characterised by depression, fatigue, hypersomnia, carbohydrate craving, and social withdrawal that tracks with reduced daylight hours — affects an estimated 3 million UK adults and reflects a failure of the circadian-melatonin-serotonin cascade in individuals genetically sensitised to photoperiod change. The retinal melanopsin cells that synchronise the master circadian clock to environmental light are particularly vulnerable in SAD patients. Treatment with pharmaceutical antidepressants for this profoundly biological condition represents one of medicine's most persistent category errors — addressing a neurotransmitter epiphenomenon while ignoring the light deficiency driving it. Bright light therapy at 10,000 lux, morning sunlight exposure, vitamin D optimisation, tryptophan-rich nutrition, and strategic blue light management at night address the actual biological mechanism with comparable or superior outcomes to antidepressant pharmacotherapy.